FEN1 and ovarian cancer: Furthermore, analysis of FEN1 expression in large cohorts of breast and ovarian cancer has correlated FEN1 overexpression at mRNA and protein level with poor prognosis and treatment response to chemotherapy and endocrine therapy, suggesting the potential of FEN1 as a prognostic and predictive biomarker in these types of cancer [67].